KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Shares Issued (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Shares Issued for 17 consecutive years, with $18.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 14.29% to $18.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.0 million through Dec 2025, up 8.22% year-over-year, with the annual reading at $79.0 million for FY2025, 8.22% up from the prior year.
  • Shares Issued hit $18.0 million in Q4 2025 for Quest Diagnostics, down from $19.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $58.0 million in Q2 2022 to a low of $10.0 million in Q1 2022.
  • Historically, Shares Issued has averaged $23.8 million across 5 years, with a median of $21.0 million in 2021.
  • Biggest five-year swings in Shares Issued: tumbled 78.75% in 2021 and later surged 150.0% in 2023.
  • Year by year, Shares Issued stood at $21.0 million in 2021, then grew by 28.57% to $27.0 million in 2022, then tumbled by 55.56% to $12.0 million in 2023, then skyrocketed by 75.0% to $21.0 million in 2024, then decreased by 14.29% to $18.0 million in 2025.
  • Business Quant data shows Shares Issued for DGX at $18.0 million in Q4 2025, $19.0 million in Q3 2025, and $13.0 million in Q2 2025.